In disease states where SMN is expressed in trace amounts or is absent, such as in the mouse model used here and in the most severely affected SMA patients with congenital presentations, SMA manifests as more than a motor neuron disease (Hamilton and Gillingwater, 2013; Nash et al, 2016). The gene discussed is SMN2; the disease is motor neuron disorder.